Interní Med. 2012; 14(8-9): 322-326

Elevated level of creatine kinase

MUDr.Stanislav Voháňka, CSc., MBA
Neurologická klinika LF MU a FN Brno
Středoevropský technologický institut, CEITEC MU, Brno

Creatine kinase is one of the key enzymes of the energy cell system. Creatine kinase catalyses the conversion of creatine and consumes adenosine

triphosphate (ATP) to create phosphocreatine and adenosine diphosphate (ADP) and vice versa. Phosphocreatine serves as an

energy reservoir, especially in active tissues. Cytosolic CK consist of three, mitochondrial is created by two isoenzymes. Creatine kinase

serum level is considered as the most sensitive laboratory parameter of the muscle damage. The elevation could be found also in other

circumstances such physical exercise, muscle injury, pregnancy, malignancy, heavy drinking, drugs abuse, diabetes, thyroid diseases,

medication or in some peripheral nerve disorders. Chronic elevation of the CK is named hyperCKemia. Among primary muscle diseases

reflects the elevated level of CK the extent of the sarcolemmal (muscle cell membrane) destruction or the whole muscle fiber necrosis.

Keywords: creatine kinase, myopathy, muscle dystrophy, rhabdomyolysis

Published: September 20, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Voháňka S. Elevated level of creatine kinase. Interní Med. 2012;14(8-9):322-326.
Download citation

References

  1. Anflous K, Veksler V, Mateo P, Samson F, Saks V, Ventura-Clapier R. Mitochondrial creatine kinase isoform expression does not correlate with its mode of action. Biochem J. 1997 Feb 15; 322(Pt 1): 73-78. Go to original source... Go to PubMed...
  2. Okinaka S, Sugita H, Momoi H, Toyokura Y, Kumagai H, Ebashi S, et al. Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Trans Am Neurol Assoc. 1959; 84: 62-64. Go to PubMed...
  3. Cardy CM, Potter T. The predictive value of creatine kinase, EMG and MRI in diagnosing muscle disease. Rheumatology (Oxford). 2007 Oct; 46(10): 1617-1618. Go to original source... Go to PubMed...
  4. Khan FY. Rhabdomyolysis: a review of the literature. Neth. J. Med. 2009 Oct; 67(9): 272-283.
  5. Frank M, Finsterer J. Creatine kinase elevation, lactacidemia, and metabolic myopathy in adult patients with diabetes mellitus. Endocr Pract. 2012 May 1; 18(3): 387-393. Go to original source... Go to PubMed...
  6. Prelle A, Tancredi L, Sciacco M, Chiveri L, Comi GP, Battistel A, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. Journal of Neurology. 2002; 249(3): 305-311. Go to original source... Go to PubMed...
  7. Lima AF, Evangelista T, de Carvalho M. Increased creatine kinase and spontaneous activity on electromyography, in amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol. 2003 May; 43(3): 189-192.
  8. Iłzecka J, Stelmasiak Z. Creatine kinase activity in amyotrophic lateral sclerosis patients. Neurol. Sci. 2003 Nov; 24(4): 286-287. Go to original source... Go to PubMed...
  9. Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009 Jul; 40(1): 126-129. Go to original source... Go to PubMed...
  10. Zhang Y, Huang J-J, Wang Z-Q, Wang N, Wu Z-Y. Value of muscle enzyme measurement in evaluating different neuromuscular diseases. Clin. Chim. Acta. 2012 Feb 18; 413(3-4): 520-524. Go to original source... Go to PubMed...
  11. Kyriakides T, Angelini C, Schaefer J, Sacconi S, Siciliano G, Vilchez JJ, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur. J. Neurol. 2010 Jun; 17(6): 767-773. Go to original source... Go to PubMed...
  12. Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O'Brien K, Campbell WW. Serum creatine kinase after exercise: Drawing the line between physiological response and exertional rhabdomyolysis. Muscle Nerve. 2012 Mar; 45(3): 356-362. Go to original source... Go to PubMed...
  13. Reijneveld J, Boekhorst T, Zonderland M, Kalmijn S, Notermans N. Response to exercise of patients with idiopathic hyper-CK-emia. Muscle Nerve. 2002 Dec; 26(6): 832-837. Go to original source... Go to PubMed...
  14. Finsterer J, Mittendorfer B, Neuhuber W, Loscher W. Influence of disposable, concentric needle electrodes on muscle enzyme and lactate serum levels. J. Electromyogr. Kinesiol. 2002 Aug; 12(4): 329-337. Go to original source... Go to PubMed...
  15. Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med. 2011 Jun; 78(6): 393-403. Go to original source... Go to PubMed...
  16. Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch. Intern. Med. 2005 Dec 12; 165(22): 2671-2676. Go to original source... Go to PubMed...
  17. McKenney J, Davidson M, Jacobson T, Guyton J. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am. J. Cardiol. 2006 Apr 17; 97(8A): 89C-94C. Go to original source... Go to PubMed...
  18. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis - an overview for clinicians. Crit Care. 2005 Apr; 9(2): 158-169. Go to original source... Go to PubMed...
  19. Fernandez C, de Paula AM, Figarella-Branger D, Krahn M, Giorgi R, Chabrol B, et al. Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology. 2006 May 23; 66(10): 1585-1587. Go to original source... Go to PubMed...
  20. Voháňka S, Ošlejšková H, Lukacs Z, Hlavatá J. Adultní forma Pompeho nemoci v ČR, rok druhý. Cesk Slov Neurol N. 2010; 73/106(4): S470.
  21. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain. 1989 Jun; 112 (Pt 3): 727-747. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.